drugset / Trial / NCT02912182

Acute Unilateral Vestibulopathy and Corticosteroid Treatment

NCT02912182

Phase 4 Terminated 78 enrolled Lund University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Randomized placebo controlled trial on patients suffering from acute unilateral vestibulopathy. Patients will be randomized into 3 arms; 1) Placebo only, 2) Short corticosteroid treatment (3days) 3) Longer corticosteroid treatment (11 days). Vestibular function as well as subjective symptoms will be estimated in the acute stage and regularly up to one year after the debut.

Timeline

Start
2015-12
Primary completion
2021-03-01
Completion
2021-03-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Betamethasone Other / unclassified 8 mg Intravenous
Comparator Prednisolone Other / unclassified 5 mg Oral